Abstract
Summary
IVF Blastocyst Medium is intended for use during in vitro fertilization procedures for extended culture and transfer of embryos. Designed to provide the necessary nutrients to support blastulation, differentiation, and expansion. Has a higher glucose concentration for blastocyst metabolism and energy production.
The global market for IVF Blastocyst Medium was estimated to be worth US$ 211 million in 2023 and is forecast to a readjusted size of US$ 260.6 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030
In vitro fertilization blastocyst medium is a special liquid medium for culturing blastocysts during in vitro fertilization. In assisted reproductive technology, in vitro fertilization is a common method used to help couples who are unable to conceive naturally due to infertility or other fertility problems achieve a child. During IVF, a woman's egg and a man's sperm combine in a laboratory to form a zygote (a fertilized egg). These fertilized eggs are then cultured until they develop into blastocysts, the most fully developed embryonic stage. Blastocyst is an important stage in embryonic development and usually completes 5-6 days after fertilization. During this process, embryos require proper culture conditions to support their normal development and proliferation. In vitro fertilization blastocyst medium is a specially formulated medium that provides the required nutrients and growth factors for blastocysts to promote their development and growth. In vitro fertilization blastocyst culture medium is usually sterile and needs to be used under strictly controlled laboratory conditions. Its formula and ingredients may vary due to different manufacturers and products, but it usually contains necessary amino acids, sugars, minerals, hormones and growth factors to provide the nutrients and environment required for embryonic growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for IVF Blastocyst Medium, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of IVF Blastocyst Medium by region & country, by Type, and by Application.
The IVF Blastocyst Medium market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVF Blastocyst Medium.
Market Segmentation
By Company
Cook Medical
CooperSurgical
Vitrolife
Kitazato Corporation
Genea Biomedx
Gynotec BV
Chengdu AIVFO Biotech
Dongyun Medical Technology
Segment by Type:
10 mL
30 mL
50 mL
100 mL
Other
Segment by Application
Hospital
Fertility Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of IVF Blastocyst Medium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of IVF Blastocyst Medium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of IVF Blastocyst Medium in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for IVF Blastocyst Medium was estimated to be worth US$ 211 million in 2023 and is forecast to a readjusted size of US$ 260.6 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030
In vitro fertilization blastocyst medium is a special liquid medium for culturing blastocysts during in vitro fertilization. In assisted reproductive technology, in vitro fertilization is a common method used to help couples who are unable to conceive naturally due to infertility or other fertility problems achieve a child. During IVF, a woman's egg and a man's sperm combine in a laboratory to form a zygote (a fertilized egg). These fertilized eggs are then cultured until they develop into blastocysts, the most fully developed embryonic stage. Blastocyst is an important stage in embryonic development and usually completes 5-6 days after fertilization. During this process, embryos require proper culture conditions to support their normal development and proliferation. In vitro fertilization blastocyst medium is a specially formulated medium that provides the required nutrients and growth factors for blastocysts to promote their development and growth. In vitro fertilization blastocyst culture medium is usually sterile and needs to be used under strictly controlled laboratory conditions. Its formula and ingredients may vary due to different manufacturers and products, but it usually contains necessary amino acids, sugars, minerals, hormones and growth factors to provide the nutrients and environment required for embryonic growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for IVF Blastocyst Medium, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of IVF Blastocyst Medium by region & country, by Type, and by Application.
The IVF Blastocyst Medium market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVF Blastocyst Medium.
Market Segmentation
By Company
Cook Medical
CooperSurgical
Vitrolife
Kitazato Corporation
Genea Biomedx
Gynotec BV
Chengdu AIVFO Biotech
Dongyun Medical Technology
Segment by Type:
10 mL
30 mL
50 mL
100 mL
Other
Segment by Application
Hospital
Fertility Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of IVF Blastocyst Medium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of IVF Blastocyst Medium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of IVF Blastocyst Medium in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 IVF Blastocyst Medium Product Introduction
1.2 Global IVF Blastocyst Medium Market Size Forecast
1.2.1 Global IVF Blastocyst Medium Sales Value (2019-2030)
1.2.2 Global IVF Blastocyst Medium Sales Volume (2019-2030)
1.2.3 Global IVF Blastocyst Medium Sales Price (2019-2030)
1.3 IVF Blastocyst Medium Market Trends & Drivers
1.3.1 IVF Blastocyst Medium Industry Trends
1.3.2 IVF Blastocyst Medium Market Drivers & Opportunity
1.3.3 IVF Blastocyst Medium Market Challenges
1.3.4 IVF Blastocyst Medium Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global IVF Blastocyst Medium Players Revenue Ranking (2023)
2.2 Global IVF Blastocyst Medium Revenue by Company (2019-2024)
2.3 Global IVF Blastocyst Medium Players Sales Volume Ranking (2023)
2.4 Global IVF Blastocyst Medium Sales Volume by Company Players (2019-2024)
2.5 Global IVF Blastocyst Medium Average Price by Company (2019-2024)
2.6 Key Manufacturers IVF Blastocyst Medium Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers IVF Blastocyst Medium Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of IVF Blastocyst Medium
2.9 IVF Blastocyst Medium Market Competitive Analysis
2.9.1 IVF Blastocyst Medium Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by IVF Blastocyst Medium Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVF Blastocyst Medium as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 10 mL
3.1.2 30 mL
3.1.3 50 mL
3.1.4 100 mL
3.1.5 Other
3.2 Global IVF Blastocyst Medium Sales Value by Type
3.2.1 Global IVF Blastocyst Medium Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global IVF Blastocyst Medium Sales Value, by Type (2019-2030)
3.2.3 Global IVF Blastocyst Medium Sales Value, by Type (%) (2019-2030)
3.3 Global IVF Blastocyst Medium Sales Volume by Type
3.3.1 Global IVF Blastocyst Medium Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global IVF Blastocyst Medium Sales Volume, by Type (2019-2030)
3.3.3 Global IVF Blastocyst Medium Sales Volume, by Type (%) (2019-2030)
3.4 Global IVF Blastocyst Medium Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Fertility Clinic
4.1.3 Other
4.2 Global IVF Blastocyst Medium Sales Value by Application
4.2.1 Global IVF Blastocyst Medium Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global IVF Blastocyst Medium Sales Value, by Application (2019-2030)
4.2.3 Global IVF Blastocyst Medium Sales Value, by Application (%) (2019-2030)
4.3 Global IVF Blastocyst Medium Sales Volume by Application
4.3.1 Global IVF Blastocyst Medium Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global IVF Blastocyst Medium Sales Volume, by Application (2019-2030)
4.3.3 Global IVF Blastocyst Medium Sales Volume, by Application (%) (2019-2030)
4.4 Global IVF Blastocyst Medium Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global IVF Blastocyst Medium Sales Value by Region
5.1.1 Global IVF Blastocyst Medium Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global IVF Blastocyst Medium Sales Value by Region (2019-2024)
5.1.3 Global IVF Blastocyst Medium Sales Value by Region (2025-2030)
5.1.4 Global IVF Blastocyst Medium Sales Value by Region (%), (2019-2030)
5.2 Global IVF Blastocyst Medium Sales Volume by Region
5.2.1 Global IVF Blastocyst Medium Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global IVF Blastocyst Medium Sales Volume by Region (2019-2024)
5.2.3 Global IVF Blastocyst Medium Sales Volume by Region (2025-2030)
5.2.4 Global IVF Blastocyst Medium Sales Volume by Region (%), (2019-2030)
5.3 Global IVF Blastocyst Medium Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America IVF Blastocyst Medium Sales Value, 2019-2030
5.4.2 North America IVF Blastocyst Medium Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe IVF Blastocyst Medium Sales Value, 2019-2030
5.5.2 Europe IVF Blastocyst Medium Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific IVF Blastocyst Medium Sales Value, 2019-2030
5.6.2 Asia Pacific IVF Blastocyst Medium Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America IVF Blastocyst Medium Sales Value, 2019-2030
5.7.2 South America IVF Blastocyst Medium Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa IVF Blastocyst Medium Sales Value, 2019-2030
5.8.2 Middle East & Africa IVF Blastocyst Medium Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions IVF Blastocyst Medium Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions IVF Blastocyst Medium Sales Value
6.2.1 Key Countries/Regions IVF Blastocyst Medium Sales Value, 2019-2030
6.2.2 Key Countries/Regions IVF Blastocyst Medium Sales Volume, 2019-2030
6.3 United States
6.3.1 United States IVF Blastocyst Medium Sales Value, 2019-2030
6.3.2 United States IVF Blastocyst Medium Sales Value by Type (%), 2023 VS 2030
6.3.3 United States IVF Blastocyst Medium Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe IVF Blastocyst Medium Sales Value, 2019-2030
6.4.2 Europe IVF Blastocyst Medium Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe IVF Blastocyst Medium Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China IVF Blastocyst Medium Sales Value, 2019-2030
6.5.2 China IVF Blastocyst Medium Sales Value by Type (%), 2023 VS 2030
6.5.3 China IVF Blastocyst Medium Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan IVF Blastocyst Medium Sales Value, 2019-2030
6.6.2 Japan IVF Blastocyst Medium Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan IVF Blastocyst Medium Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea IVF Blastocyst Medium Sales Value, 2019-2030
6.7.2 South Korea IVF Blastocyst Medium Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea IVF Blastocyst Medium Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia IVF Blastocyst Medium Sales Value, 2019-2030
6.8.2 Southeast Asia IVF Blastocyst Medium Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia IVF Blastocyst Medium Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India IVF Blastocyst Medium Sales Value, 2019-2030
6.9.2 India IVF Blastocyst Medium Sales Value by Type (%), 2023 VS 2030
6.9.3 India IVF Blastocyst Medium Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cook Medical
7.1.1 Cook Medical Company Information
7.1.2 Cook Medical Introduction and Business Overview
7.1.3 Cook Medical IVF Blastocyst Medium Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Cook Medical IVF Blastocyst Medium Product Offerings
7.1.5 Cook Medical Recent Development
7.2 CooperSurgical
7.2.1 CooperSurgical Company Information
7.2.2 CooperSurgical Introduction and Business Overview
7.2.3 CooperSurgical IVF Blastocyst Medium Sales, Revenue and Gross Margin (2019-2024)
7.2.4 CooperSurgical IVF Blastocyst Medium Product Offerings
7.2.5 CooperSurgical Recent Development
7.3 Vitrolife
7.3.1 Vitrolife Company Information
7.3.2 Vitrolife Introduction and Business Overview
7.3.3 Vitrolife IVF Blastocyst Medium Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Vitrolife IVF Blastocyst Medium Product Offerings
7.3.5 Vitrolife Recent Development
7.4 Kitazato Corporation
7.4.1 Kitazato Corporation Company Information
7.4.2 Kitazato Corporation Introduction and Business Overview
7.4.3 Kitazato Corporation IVF Blastocyst Medium Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Kitazato Corporation IVF Blastocyst Medium Product Offerings
7.4.5 Kitazato Corporation Recent Development
7.5 Genea Biomedx
7.5.1 Genea Biomedx Company Information
7.5.2 Genea Biomedx Introduction and Business Overview
7.5.3 Genea Biomedx IVF Blastocyst Medium Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Genea Biomedx IVF Blastocyst Medium Product Offerings
7.5.5 Genea Biomedx Recent Development
7.6 Gynotec BV
7.6.1 Gynotec BV Company Information
7.6.2 Gynotec BV Introduction and Business Overview
7.6.3 Gynotec BV IVF Blastocyst Medium Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Gynotec BV IVF Blastocyst Medium Product Offerings
7.6.5 Gynotec BV Recent Development
7.7 Chengdu AIVFO Biotech
7.7.1 Chengdu AIVFO Biotech Company Information
7.7.2 Chengdu AIVFO Biotech Introduction and Business Overview
7.7.3 Chengdu AIVFO Biotech IVF Blastocyst Medium Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Chengdu AIVFO Biotech IVF Blastocyst Medium Product Offerings
7.7.5 Chengdu AIVFO Biotech Recent Development
7.8 Dongyun Medical Technology
7.8.1 Dongyun Medical Technology Company Information
7.8.2 Dongyun Medical Technology Introduction and Business Overview
7.8.3 Dongyun Medical Technology IVF Blastocyst Medium Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Dongyun Medical Technology IVF Blastocyst Medium Product Offerings
7.8.5 Dongyun Medical Technology Recent Development
8 Industry Chain Analysis
8.1 IVF Blastocyst Medium Industrial Chain
8.2 IVF Blastocyst Medium Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 IVF Blastocyst Medium Sales Model
8.5.2 Sales Channel
8.5.3 IVF Blastocyst Medium Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer